China Jinmao Holdings Group Ltd (0817)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 1.200 |
|---|---|
| 52-week range | 1.131 – 1.989 |
| Return, 1 month / 3 months | −2.4% / −10.2% |
| Return, 1 year / 3 years | −15.1% / +24.0% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 52.7% |
| Worst drawdown (1 year) | -40.0% |
| Average daily value traded | 88.76M HKD |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Jinmao Holdings Group is a property developer based in Hong Kong and active across mainland China. It builds and markets residential communities, often positioned as higher-end housing, along with office and commercial properties in major cities. The company also develops and operates hotels and holds investment properties for rental income. Its customers are home buyers, businesses and hotel guests, and its activities span development, sales and property management.
China Jinmao Holdings Group Ltd trades under the code 0817 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Jinmao Holdings Group Ltd (0817) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 1.200 on 21 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,081 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.1% and over the last three months it fell 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.7% | ||
| From 52-week high | -38.5% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.2% | ||
| 6-month return | -21.1% | ||
| 12-month return, skipping the last month | -13.0% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 52.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.0% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 88.76M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.3% |
|---|---|
| 1 month | −2.4% |
| 3 months | −10.2% |
| 6 months | −21.1% |
| 1 year | −15.1% |
| 3 years | +24.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.318 / 1.423 |
|---|---|
| Golden / death cross (60 days) | Death, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.063 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Sep 2026 | HKD 0.0300 |
| 15 Sep 2025 | HKD 0.0300 |
| 13 Sep 2024 | HKD 0.0300 |
| 18 Sep 2023 | HKD 0.0150 |
| 30 Jun 2023 | HKD 0.0200 |
| 9 Jun 2023 | HKD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.